ELIZABETH ESTURBAN: Open Payments
NPI 1417727389 · NEW BERN, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$238 in 14 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $238 · 2025 $238
Food & beverage: $238
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $54 |
| Lilly USA, LLC | 3 | $50 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $45 |
| ABBVIE INC. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
| Dexcom, Inc. | 1 | $14 |
Products named: MOUNJARO, XIFAXAN, SHINGRIX, VRAYLAR, OPSUMIT, TRELEGY ELLIPTA, JOURNAVX, Rybelsus.
Industry payments across NC — which companies pay providers there.
